Cancer Therapy : Preclinical Combined Targeting of STAT 3 / NFk B / COX-2 / EP 4 for Effective Management of Pancreatic Cancer
暂无分享,去创建一个
Huamin Wang | S. Kopetz | J. Freeman | S. Fischer | Addanki P. Kumar | R. Bedolla | R. Reddick | Jianping Xie | Jingjing Gong | P. Rivas | D. Chakravarthy | A. Peterson | Jianping Xie
[1] David J Newman,et al. Natural products: a continuing source of novel drug leads. , 2013, Biochimica et biophysica acta.
[2] M. Tempero,et al. Therapeutic advances in pancreatic cancer. , 2013, Gastroenterology.
[3] R. Hwang,et al. Prostaglandin E2 Regulates Pancreatic Stellate Cell Activity Via the EP4 Receptor , 2013, Pancreas.
[4] G. K. Gray,et al. Activation of the NF-κB Pathway by the STAT3 Inhibitor JSI-124 in Human Glioblastoma Cells , 2013, Molecular Cancer Research.
[5] N. Jamieson,et al. Exploiting inflammation for therapeutic gain in pancreatic cancer , 2013, British Journal of Cancer.
[6] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[7] J. Fagin,et al. STAT3 negatively regulates thyroid tumorigenesis , 2012, Proceedings of the National Academy of Sciences.
[8] Alexander A. Fingerle,et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications , 2012, Nature Reviews Gastroenterology &Hepatology.
[9] L. Tran,et al. Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development , 2012, Molecular Cancer Therapeutics.
[10] S. Narumiya,et al. The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. , 2012, Kidney international.
[11] H. Eguchi,et al. Perineural Invasion and Lymph Node Involvement as Indicators of Surgical Outcome and Pattern of Recurrence in the Setting of Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Pancreatic Cancer , 2012, Annals of surgery.
[12] Xuelian Xu,et al. Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines. , 2011, Molecular medicine reports.
[13] 中川 直樹. The intrinsic prostaglandin E₂-EP₄ system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice , 2012 .
[14] Y. Daaka,et al. Prostaglandin E2 Regulates Renal Cell Carcinoma Invasion through the EP4 Receptor-Rap GTPase Signal Transduction Pathway* , 2011, The Journal of Biological Chemistry.
[15] X. Le,et al. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. , 2011, Cancer research.
[16] Hua Yu,et al. A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-κB in tumors. , 2011, Cancer research.
[17] B. Fridley,et al. Inflammation-Related Gene Variants as Risk Factors for Pancreatic Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[18] M. Karin,et al. NF-κB and STAT3 – key players in liver inflammation and cancer , 2011, Cell Research.
[19] A. Bode,et al. Breaking the NF-κB and STAT3 Alliance Inhibits Inflammation and Pancreatic Tumorigenesis , 2010, Cancer Prevention Research.
[20] I. Thompson,et al. Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer management. , 2010, Mini reviews in medicinal chemistry.
[21] M. Karin,et al. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. , 2010, Cytokine & growth factor reviews.
[22] E. White,et al. Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] D. Troyer,et al. Involvement of FLIP in 2-Methoxyestradiol–Induced Tumor Regression in Transgenic Adenocarcinoma of Mouse Prostate Model , 2009, Clinical Cancer Research.
[24] A. Masamune,et al. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells , 2008, Gut.
[25] G. Feldmann,et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice , 2008, Proceedings of the National Academy of Sciences.
[26] S. Srivastava,et al. In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway , 2008, Apoptosis.
[27] M. McArthur,et al. Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. , 2008, Neoplasia.
[28] V. Go,et al. Expression Analysis of the Prostaglandin E2 Production Pathway in Human Pancreatic Cancers , 2008, Pancreas.
[29] P. Kochunov,et al. Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a Phellodendron Amurense Bark Extract , 2007, Clinical Cancer Research.
[30] B. Aggarwal,et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. , 2007, Cancer research.
[31] D. Scholtens,et al. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. , 2006, The Journal of surgical research.
[32] K. Sugano,et al. Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cytokines. , 2007, American journal of physiology. Cell physiology.
[33] A. Pozzi,et al. EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival , 2006, Oncogene.
[34] N. Kyprianou,et al. Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract. , 2006, Neoplasia.
[35] R. DePinho,et al. Genetics and biology of pancreatic ductal adenocarcinoma. , 2006, Genes & development.
[36] M. Hollingsworth,et al. Notch2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells , 2005, Laboratory Investigation.
[37] A. Masamune,et al. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells. , 2005, World journal of gastroenterology.
[38] M. Hull,et al. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? , 2004, Molecular cancer therapeutics.
[39] B. Wiedenmann,et al. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. , 2003, Gastroenterology.
[40] J. Abbruzzese,et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis , 2003, Oncogene.
[41] Douglas B. Evans,et al. Function of nuclear factor kappaB in pancreatic cancer metastasis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[42] S. Gansauge,et al. Cyclooxygenase-2 is Overexpressed in Chronic Pancreatitis , 2002, Pancreas.
[43] S. Narumiya,et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. , 2002, The Journal of clinical investigation.
[44] R. Breyer,et al. Prostaglandin E receptors and the kidney. , 2000, American journal of physiology. Renal physiology.
[45] D. Heilman,et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. , 2000, Carcinogenesis.
[46] M. Monden,et al. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[47] M. Abramovitz,et al. Nuclear localization of prostaglandin E2 receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[48] S. Laulederkind,et al. Compensatory Prostaglandin E2 Biosynthesis in Cyclooxygenase 1 or 2 Null Cells , 1998, The Journal of experimental medicine.